Presentation Format and Category
Type of Session
- Under-40 Session: Oral Presentation Only
- Requested Papers: Oral Presentation Only
- Free Papers: Oral Presentation or Poster Presentation
*The final selection of the presentation style is to be determined by the organizer.
Category
| No |
Session Type |
Category |
| 01 |
Under-40 Session |
Challenge to break through the current radiation oncology |
| 02 |
Requested Paper 1 |
Altered fractionation |
| 03 |
Requested Paper 2 |
Artificial Intelligence (A.I.) |
| 04 |
Requested Paper 3 |
Rare late toxicities |
| 05 |
Requested Paper 4 |
Oncology team |
| 06 |
Free Paper 01 |
Radiation biology |
| 07 |
Free Paper 02 |
IMRT |
| 08 |
Free Paper 03 |
IGRT |
| 09 |
Free Paper 04 |
SRS, SRT |
| 10 |
Free Paper 05 |
Particle therapy |
| 11 |
Free Paper 06 |
Brachytherapy |
| 12 |
Free Paper 07 |
Treatment planning |
| 13 |
Free Paper 08 |
Tracking / Gating |
| 14 |
Free Paper 09 |
Dosimetry |
| 15 |
Free Paper 10 |
Set-up Accuracy |
| 16 |
Free Paper 11 |
QA, QC |
| 17 |
Free Paper 12 |
Radiation physics |
| 18 |
Free Paper 13 |
Big data |
| 19 |
Free Paper 14 |
CNS |
| 20 |
Free Paper 15 |
Head and Neck cancer |
| 21 |
Free Paper 16 |
Lung cancer |
| 22 |
Free Paper 17 |
Breast cancer |
| 23 |
Free Paper 18 |
Esophageal cancer |
| 24 |
Free Paper 19 |
GI cancer |
| 25 |
Free Paper 20 |
Liver, Gall Bladder, and Pancreatic cancer |
| 26 |
Free Paper 21 |
Prostate cancer |
| 27 |
Free Paper 22 |
GU cancer |
| 28 |
Free Paper 23 |
GYN cancer |
| 29 |
Free Paper 24 |
Lymphoma, Leukemia |
| 30 |
Free Paper 25 |
Pediatric malignancy |
| 31 |
Free Paper 26 |
Sarcoma, Cutaneous tumors |
| 32 |
Free Paper 27 |
Benign disease |
| 33 |
Free Paper 28 |
Re-irradiation |
| 34 |
Free Paper 29 |
Toxicities |
| 35 |
Free Paper 30 |
Elderly patients |
| 36 |
Free Paper 31 |
Immuno-radiotherapy |
| 37 |
Free Paper 32 |
Palliative care |
| 38 |
Free Paper 33 |
Case report, Rare disease |
| 39 |
Free Paper 34 |
Others |
| 40 |
Free Paper 35 |
Nursing |
Copyright © The 31st Annual Meeting of the Japanese Society for Radiation Oncology. All Rights Reserved.